Data / Drug companies / Osmotic Laxative
Osmotic Laxative drugs: 207 drugs from 365 companies in the FDA NDC directory
Osmotic Laxative is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 2,352 products in this class from 365 companies, covering 207 drugs by generic name. The main marketing category is unapproved homeopathic products, and the newest product started marketing on October 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 365Companies
- 2,352Products
- 207Drugs by generic name
Drugs in the Osmotic Laxative class
Ranked by number of companies that list the drug.
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hahnemann Laboratories, Inc. | 202 | pellet | Unapproved homeopathic products | September 14, 2023 |
| Baxter Healthcare Corporation | 92 | injection, solution; injection | New drug applications (NDA) | January 8, 2026 |
| Fresenius Kabi USA, LLC | 49 | injection, solution; injection | Generic drugs (ANDA) | December 19, 2025 |
| B. Braun Medical Inc. | 43 | injection, solution; injection | New drug applications (NDA) | October 1, 2026 |
| Boiron | 43 | pellet; tablet | Unapproved homeopathic products | January 1, 2025 |
| Newton Laboratories, Inc. | 41 | liquid; pellet | Unapproved homeopathic products | November 26, 2024 |
| Professional Complementary Health Formulas | 39 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Deseret Biologicals, Inc. | 38 | liquid | Unapproved homeopathic products | June 25, 2026 |
| Fresenius Kabi USA, LLC | 38 | injection, solution; injection, solution, concentrate | Generic drugs (ANDA) | July 11, 2023 |
| Icu Medical Inc. | 34 | injection, solution; irrigant | New drug applications (NDA) | February 8, 2021 |
| Walgreen Company | 34 | liquid; tablet, chewable | Over the counter monograph drugs | July 20, 2026 |
| BM Private Limited | 33 | globule; tablet | Unapproved homeopathic products | January 1, 2015 |
| Vantive US Healthcare LLC | 33 | injection, solution | Unapproved drugs for a shortage | November 7, 2024 |
| Hyland's Inc. | 30 | tablet; tablet, soluble | Unapproved homeopathic products | December 1, 2022 |
| A-S Medication Solutions | 29 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| BioActive Nutritional, Inc. | 29 | liquid | Unapproved homeopathic products | September 10, 2026 |
| Apex Energetics Inc. | 28 | solution/ drops; solution | Unapproved homeopathic products | March 22, 2022 |
| PureTek Corporation | 28 | tablet; capsule | Other unapproved drugs | August 21, 2026 |
| Total Operations Management LLC DBA:Bestmade Natural Products Micro | 27 | globule; tablet | Unapproved homeopathic products | June 1, 2026 |
| Dna Labs, Inc. | 26 | solution | Unapproved homeopathic products | February 11, 2023 |
| Hospira, Inc. | 26 | injection, solution; injection, solution, concentrate | New drug applications (NDA) | September 29, 2025 |
| Energique, Inc. | 22 | liquid | Unapproved homeopathic products | February 18, 2026 |
| Siddha Flower Essences LLC | 22 | spray | Unapproved homeopathic products | September 17, 2022 |
| Silver Star Brands | 21 | liquid; tablet | Unapproved homeopathic products | April 3, 2023 |
| Cardinal Health 110, LLC. DBA Leader | 17 | suspension; powder, for solution | Over the counter monograph drugs | November 8, 2024 |
| Geri-Care Pharmaceuticals, Corp | 17 | liquid; suspension | Over the counter monograph drugs | January 1, 2026 |
| Major Pharmaceuticals | 16 | suspension; tablet, extended release | Generic drugs (ANDA) | August 28, 2026 |
| CVS Pharmacy | 15 | liquid; suspension | Over the counter monograph drugs | October 14, 2022 |
| HF Acquisition Co LLC, DBA HealthFirst | 15 | injection, solution; injection, solution, concentrate | New drug applications (NDA) | July 17, 2021 |
| Pai Holdings, LLC DBA Pai Pharma | 15 | solution; suspension | Generic drugs (ANDA) | March 17, 2025 |
| Talbot's Pharmaceuticals Family Products, LLC. | 15 | liquid; tablet, soluble | Unapproved homeopathic products | September 28, 2022 |
| Valu Merchandisers Company | 15 | suspension; liquid | Over the counter monograph drugs | September 24, 2020 |
| Cardinal Health 107, LLC | 14 | powder, for solution; solution | Generic drugs (ANDA) | August 24, 2026 |
| Guna Spa | 14 | solution/ drops; pellet | Unapproved homeopathic products | February 17, 2021 |
| Ohm Pharma Inc. | 14 | liquid; gel | Unapproved homeopathic products | November 20, 2017 |
| Safeway | 14 | liquid; tablet, chewable | Over the counter monograph drugs | March 6, 2026 |
| Strategic Sourcing Services LLC | 14 | suspension; granule | Over the counter monograph drugs | October 31, 2023 |
| Wal-Mart Stores Inc | 14 | suspension; powder, for solution | Over the counter monograph drugs | June 15, 2020 |
| Amerisource Bergen | 13 | liquid; powder, for solution | Over the counter monograph drugs | March 10, 2026 |
| Bryant Ranch Prepack | 13 | tablet, extended release; tablet | Generic drugs (ANDA) | April 10, 2023 |
| CVS Woonsocket Prescription Center, Incorporated | 13 | liquid; tablet, chewable | Over the counter monograph drugs | September 25, 2026 |
| Martin & Pleasance Pty Ltd | 13 | tablet, chewable; spray | Unapproved homeopathic products | September 1, 2025 |
| Nutritional Specialties, Inc. | 13 | liquid; spray | Unapproved homeopathic products | September 19, 2025 |
| Topco Associates LLC | 13 | liquid; tablet, chewable | Over the counter monograph drugs | December 1, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 12 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Kroger Company | 12 | suspension; powder, for solution | Over the counter monograph drugs | June 20, 2024 |
| Uriel Pharmacy Inc. | 12 | liquid; powder | Unapproved homeopathic products | September 1, 2009 |
| American Health Packaging | 11 | solution; suspension | Generic drugs (ANDA) | August 16, 2026 |
| Avadim Holdings, Inc. | 11 | aerosol, foam; spray | Unapproved homeopathic products | January 1, 2025 |
| Chain Drug Marketing Association, Inc. | 11 | liquid; suspension | Over the counter monograph drugs | October 1, 2026 |
| Chattem, Inc. | 11 | tablet, chewable; liquid | Over the counter monograph drugs | September 30, 2025 |
| Meijer, Inc. | 11 | liquid; suspension | Over the counter monograph drugs | December 1, 2025 |
| Dolgencorp, Inc. (dollar General & Rexall) | 10 | liquid; powder, for solution | Over the counter monograph drugs | March 17, 2025 |
| H E B | 10 | suspension; liquid | Over the counter monograph drugs | February 7, 2025 |
| Infirst Healthcare Inc. | 10 | suspension; liquid | Over the counter monograph drugs | August 15, 2026 |
| Kesin Pharma Corporation | 10 | suspension; solution | Generic drugs (ANDA) | November 5, 2025 |
| Lupin Pharmaceuticals,Inc. | 10 | powder, for solution; solution | Generic drugs (ANDA) | December 30, 2022 |
| Perrigo Direct, Inc | 10 | suspension; liquid | Over the counter monograph drugs | July 1, 2020 |
| Preferred Pharmaceuticals Inc. | 10 | liquid; powder, for solution | Generic drugs (ANDA) | December 19, 2024 |
| Rugby Laboratories | 10 | liquid; suspension | Over the counter monograph drugs | June 2, 2021 |
| TRP Company | 10 | tablet, orally disintegrating; spray | Unapproved homeopathic products | April 30, 2025 |
| Advagen Pharma Ltd | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 22, 2024 |
| Amazon.com Services LLC | 9 | powder, for solution; capsule, gelatin coated | Generic drugs (ANDA) | August 27, 2026 |
| Atlantic Biologicals Corp. | 9 | solution; powder, for solution | Generic drugs (ANDA) | October 5, 2023 |
| Fresenius Medical Care Renal Therapies Group, LLC | 9 | solution; injection | New drug applications (NDA) | April 12, 2007 |
| Henry Schein, Inc. | 9 | injection, solution; injection, solution, concentrate | Generic drugs (ANDA) | January 18, 2022 |
| Retail Business Services, LLC | 9 | liquid; powder, for solution | Over the counter monograph drugs | May 16, 2024 |
| Strides Pharma Science Limited | 9 | powder, for solution; tablet, extended release | Generic drugs (ANDA) | January 17, 2024 |
| Upsher-Smith Laboratories, LLC | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 15, 2025 |
| Vantive US Healthcare LLC | 9 | injection | New drug applications (NDA) | January 13, 2015 |
| Walmart Inc. | 9 | liquid; tablet, chewable | Over the counter monograph drugs | March 4, 2026 |
| Bayer HealthCare LLC. | 8 | tablet, effervescent; liquid | Over the counter monograph drugs | February 16, 2022 |
| Becton Dickinson and Company | 8 | injection, solution | Generic drugs (ANDA) | November 14, 2025 |
| Chain Drug Marketing Association | 8 | liquid; suspension | Over the counter monograph drugs | February 18, 2020 |
| Granules Pharmaceuticals Inc. | 8 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | April 25, 2021 |
| Meijer Distribution Inc | 8 | tablet, chewable; capsule, gelatin coated | Over the counter monograph drugs | April 3, 2020 |
| Natural Creations, Inc | 8 | liquid | Unapproved homeopathic products | March 5, 2019 |
| WG Critical Care, LLC | 8 | injection | Generic drugs (ANDA) | January 9, 2018 |
| Avion Pharmaceuticals, LLC | 7 | capsule, gelatin coated; tablet, coated | Other unapproved drugs | November 18, 2014 |
| BluePoint Laboratories | 7 | tablet; capsule, extended release | Generic drugs (ANDA) | July 10, 2024 |
| Bryant Ranch Prepack | 7 | powder, for solution; tablet | Generic drugs (ANDA) | January 1, 2021 |
| Bryant Ranch Prepack | 7 | tablet, extended release; tablet | Generic drugs (ANDA) | June 17, 2020 |
| Camber Pharmaceuticals, Inc. | 7 | solution; tablet, extended release | Generic drugs (ANDA) | May 28, 2025 |
| Carwin Pharmaceutical Associates, LLC | 7 | tablet, chewable; powder, for solution | Other unapproved drugs | January 14, 2026 |
| Discount Drug Mart | 7 | liquid; tablet, chewable | Over the counter monograph drugs | February 26, 2025 |
| Energetix Corporation | 7 | liquid | Unapproved homeopathic products | January 1, 2019 |
| Evi Labs | 7 | powder; granule, effervescent | Over the counter monograph drugs | August 24, 2026 |
| Family Dollar (family Wellness) | 7 | suspension; liquid | Over the counter monograph drugs | September 4, 2024 |
| Kadesh Incoporation Co,Ltd | 7 | liquid; spray | Unapproved homeopathic products | August 22, 2023 |
| L. Perrigo Company | 7 | powder, for solution; tablet, chewable | Generic drugs (ANDA) | November 20, 2025 |
| NaturalCare | 7 | tablet, chewable; tablet | Unapproved homeopathic products | March 25, 2026 |
| Oncora Pharma, LLC | 7 | tablet | Other unapproved drugs | October 22, 2026 |
| Remedyrepack Inc. | 7 | tablet, extended release; injection, solution | Generic drugs (ANDA) | November 21, 2025 |
| Seroyal USA | 7 | tablet; liquid | Unapproved homeopathic products | December 18, 2018 |
| Sevene USA | 7 | pellet | Unapproved homeopathic products | June 26, 2023 |
| Zettl Health Inc. | 7 | pellet | Unapproved homeopathic products | June 11, 2026 |
| Homeocare Laboratories | 6 | pellet | Unapproved homeopathic products | July 24, 2012 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 6 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 7, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Publix Super Markets Inc | 6 | solution; suspension | Over the counter monograph drugs | August 17, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 463 | 19.7% |
| Pellet | 286 | 12.2% |
| Injection, solution | 275 | 11.7% |
| Powder, for solution | 157 | 6.7% |
| Solution | 152 | 6.5% |
| Tablet | 140 | 6% |
| Suspension | 111 | 4.7% |
| Tablet, extended release | 102 | 4.3% |
| Tablet, chewable | 102 | 4.3% |
| Injection | 89 | 3.8% |
| Spray | 57 | 2.4% |
| Tablet, film coated, extended release | 49 | 2.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.